Effects of pomegranate juice (Punica Granatum) on inflammatory biomarkers and complete blood count in patients with COVID-19: a structured summary of a study protocol for a randomized clinical trial

Effects of pomegranate juice (Punica Granatum) on inflammatory biomarkers and complete blood count in patients with COVID-19: a structured summary of a study protocol for a randomized clinical trial

This study is conducted to investigate efficacy of pomegranate juice on inflammatory biomarkers, C-reactive protein (CRP), interleukin 6(IL-6), erythrocyte sedimentation rate (ESR) and complete blood count (CBC) in hospitalized patients with mild to moderate coronavirus disease 2019 (COVID- 19). Thi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current controlled trials in cardiovascular medicine 2021-04, Vol.22 (1), p.246-246, Article 246
Hauptverfasser: Yousefi, Mojtaba, Sadriirani, Mohammadreza, PourMahmoudi, Azizollah, Mahmoodi, Sara, Samimi, Bahar, Hosseinikia, Mahboobe, Saeedinezhad, Zaker, Panahande, Seyed Bahman
Format: Artikel
Sprache:eng
Schlagworte:
Analysis
Biological markers
Biomarkers
Blood Cell Count
Blood Sedimentation
Blood tests
C-Reactive Protein - immunology
Clinical trials
Coronaviruses
COVID-19
COVID-19 - blood
COVID-19 - immunology
COVID-19 - therapy
CRP
Double-Blind Method
Fruit and Vegetable Juices
Fruit juices
Health aspects
Hospitalization
Humans
IL-6
Interleukin-6 - immunology
Letter
Pomegranate
Pomegranate Juice
Protocol
Randomized Controlled Trial
Randomized Controlled Trials as Topic
Registration
SARS-CoV-2
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This study is conducted to investigate efficacy of pomegranate juice on inflammatory biomarkers, C-reactive protein (CRP), interleukin 6(IL-6), erythrocyte sedimentation rate (ESR) and complete blood count (CBC) in hospitalized patients with mild to moderate coronavirus disease 2019 (COVID- 19). This is a randomized, placebo-controlled, double-blind, parallel 2-arm (1:1 ratio) clinical trial. Patients with COVID-19 admitted to hospitals in Yasuj City, Kohgiluyeh and Boyer-Ahmad Province, Iran. Informed consent Patients 18 years of age or older Diagnosis of COVID-19 based on real-time polymerase chain reaction (RT-PCR) test EXCLUSION CRITERIA: Pregnancy or lactation Immunoglobulin A (IgA) level
ISSN:1745-6215
1745-6215
DOI:10.1186/s13063-021-05194-9